Skip Ribbon Commands
Skip to main content
CIBMTR

Study Lists

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   /   Studies   /   Clinical Outcomes Research   /   Study Lists   /   Observational Studies
  • Print
  • Share

 


Regimen-Related Toxicity and Supportive Care Working Committee Studies

The Regimen-Related Toxicity and Supportive Care Working Committee provides scientific oversight for studies related to preparative regimens, prevention and treatment of early non-Graft-versus-Host Disease toxicities and supportive care in the early post-transplant period.

Learn more about the studies conducted through the Regimen-Related Toxicity and Supportive Care Working Committee using the links below.

Recently Completed Studies

NumberTitleStatus
RT12-04 Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders Published
RT12-03 Transplant in older adults: is it feasible in those 70 years and older? Published
RT12-01 The sequence of cyclophosphamide and myeloablative total body irradiation in hematopoietic cell transplant for patients with acute leukemia Published
RT11-01 Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation Published
RT10-01
IB12-05
C-reactive protein to predict non-relapse mortality after allogeneic hematopoietic cell transplantation Published
RT10-01 C-reactive protein to predict non-relapse mortality after allogeneic hematopoietic cell transplantation Published
RT09-04
IB09-06d
Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant Published
RT09-04
IB09-06c
A case-control genome-wide association study of acute myelogeneous leukemia and myelodysplastic syndromes with the Genetics and Epidemiology of Myeloid Malignancies consortium Published
RT09-04
IB09-06b
Genetic susceptibility to transplant-related mortality after unrelated donor hematopoietic cell transplant Published
RT09-04
IB09-06a
Establishment of definitions and review process for consistent adjudication of ause-specific mortality after allogeneic unrelated donor hematopoietic cell transplantation Published
RT09-02 Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. Published
RT09-01 Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies Published
RT07-01a Prospective validation of the predictive power of the hematopoietic cell transplantation comorbidity index: a CIBMTR® study Published

Last Updated: 12/7/2017 11:36 AM
CIBMTR